Giant Cell Arteritis
Giant Cell Arteritis is an inflammation of the blood vessels, often affecting the arteries in the head, which can lead to headaches, vision problems, and jaw pain.
Giant Cell Arteritis and Rheumatoid Arthritis: PET/CT Imaging Study
We are testing a new imaging method to see inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis. This study aims to improve how we visualize and understand these conditions.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Rheumatoid Arthritis
Rheumatoid Arthritis is an autoimmune disorder that primarily affects joints, causing pain, swelling, and stiffness, and can also impact other systems in the body.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 50 years old?
- Are you currently pregnant or breastfeeding?
- Have you taken any oral or injectable steroids in the last 4 weeks?
- Are you currently taking any disease-modifying anti-rheumatic drugs (DMARDs) like Methotrexate or Sulfasalazine?
- Are you under 30 years old?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zirconium
Crefmirlimab Berdoxam
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
VUmc Stichting
Rheumatology and Clinical Immunology
Amstelveen, Netherlands
UMCG
Rheumatology and Clinical Immunology
Groningen, Netherlands
Sponsor: Universitair Medisch Centrum Groningen
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.